|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Other amortization | |||||
| Stock-based compensation | |||||
| Accelerated amortization of stock-based compensation | |||||
| Straight-line rent receivables | |||||
| Impairments, net of net gains on the sales of depreciable real estate assets | |||||
| Gain on sale of real estate | |||||
| (Gains) on the sales of depreciable real estate assets, net of losses and impairments | |||||
| Credit loss reserve | |||||
| Net gain from insurance recovery on casualty loss | |||||
| Deferred income tax expense | |||||
| Changes in operating assets and liabilities: | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Acquisitions of real estate | |||||
| Proceeds from the sale of real estate | |||||
| Funding of notes receivable | |||||
| Proceeds from repayments on notes receivable | |||||
| Insurance proceeds from casualty loss | |||||
| Capital expenditures on existing real estate properties | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net borrowings on revolving credit facility | |||||
| Term loan borrowings | |||||
| Term loan repayments | |||||
| Mortgage note repayments | |||||
| Dividends paid | |||||
| Proceeds from issuance of common stock | |||||
| Taxes paid on behalf of employees and shares withheld upon shares vesting | |||||
| Equity issuance costs | |||||
| Debt issuance costs | |||||
| Net cash (used in) provided by financing activities | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Cash Flow Information: | |||||
| Interest paid | |||||
| Invoices accrued for construction, tenant improvement and other capitalized costs | |||||
| Reclassification of registration statement costs to equity issuance costs | |||||
| (Decrease) increase in fair value of cash flow hedges | |||||
| Capitalized interest | |||||
Loading...